How can you manage your company through the recession and position yourself for growth? After interviewing thousands of life sciences executives, we identified some overarching themes. From managing risks to improving capital allocation, we reveal the lessons that could mean the difference between surviving and thriving in the new economic environment.
Why B.C.’s biotech industry is falling behind
(As originally appeared in the Vancouver Sun, 18 September 2009) British Columbia’s biotechnology sector is no stranger to the downside of a cycle. But this time, there are concerns that the road to recovery may be harder and more complex than in previous downturns. The problems are deep-rooted, systemic and persistent.
Canadian biotech faces time of reckoning
Our new report, Beyond borders: Global biotechnology report 2009, reveals that without new approaches and funding sources, the next few years could cripple the biotech industry in Canada. Read the press release for highlights of the report.
Contacts
Rod Budd Canadian Leader Biotechnology Montreal 514 879 2605
Industry 360º
The financial crisis. Climate change. IFRS. Read our industry-focused insights on these hot topics and more at www.ey.com/industry360.
/$FILE/14L00232.JPG)